Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06351332
Status:
SUSPENDED
Last Update Posted:
2024-06-20
First Post:
2024-04-02
Brief Title:
ZAP-IT ZN-c3 Carboplatin Pembrolizumab in MTNBC
Sponsor:
Filipa Lynce MD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
24-005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Filipa Lynce MD
Lead Sponsor Class:
OTHER
Responsible Party:
Filipa Lynce MD
Responsible Party Title:
Sponsor Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Zentalis Pharmaceuticals | UNKNOWN |
| Merck Sharp Dohme LLC | INDUSTRY |